We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





AI-based Infectious Disease Surveillance System Sent First Warning of Novel Coronavirus

By HospiMedica International staff writers
Posted on 28 Apr 2020
Print article
Image: BlueDot’s AI engine (Photo courtesy of BlueDot)
Image: BlueDot’s AI engine (Photo courtesy of BlueDot)
An artificial intelligence (AI) warning system run by digital health firm BlueDot (Toronto, Canada) was among the first in the world to identify the emerging risk from COVID-19 in Hubei province and notify its clients via the company’s Insights platform.

BlueDot’s AI engine had earlier successfully predicted that the Zika virus would spread to Florida six months before it happened and the 2014 Ebola outbreak would leave West Africa. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. The company empowers national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats. BlueDot was among the first in the world to identify the emerging risk from, and publish a scientific paper on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses.

BlueDot anticipates the impact of disease spread globally and globally using diverse datasets such as billions of flight itineraries, real time climate conditions, health system capacity, and animal & insect populations. BlueDot disseminates bespoke, near-real-time insights to clients including governments, hospitals and airlines, revealing COVID-19’s movements. The company’s intelligence is based on over 40 pathogen-specific datasets reflecting disease mobility and outbreak potential. BlueDot also delivers regular reporting to answer the most pressing questions, including which countries reported local cases, how severely cities outside of China were affected, and which cities risked transmitting COVID-19 despite having no official cases.

Related Links:
BlueDot

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Computerized Spirometer
DatospirAira

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.